NCT03875820 2026-03-10FRAMEInstitute of Cancer Research, United KingdomPhase 1 Active not recruiting87 enrolled
NCT05798507 2025-12-15Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With GlioblastomaEmory UniversityPhase EARLY_PHASE1 Active not recruiting14 enrolled